These unconventional CD8+ T cells are an intrinsic feature of the 68–1 strain resulting in MHC-II and MHC-E-restricted responses to heterologous antigens inserted into RhCMV, as previously shown for SIV and TB, as well as to RhCMV proteins [27–29]. This evidence concerns the gene CD8A and tuberculosis.